Camille Lefevre

Gut microbiota-dependent phenylpropanoic acid derivatives reduced in cancer cachexia protect against myotube atrophy

By identifying microbiota-dependent metabolites as potential therapeutic levers, the current work not only advances the understanding of microbiome-host crosstalk in disease but also opens avenues for innovative, targeted interventions to mitigate muscle atrophy.